Navigation Links
Thoratec Schedules First Quarter Conference Call, Webcast
Date:4/20/2012

PLEASANTON, Calif., April 20, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal year 2012 on Tuesday, May 1.

The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Tuesday, May 1, hosted by Gary F. Burbach, President and Chief Executive Officer.

The teleconference can be accessed by calling (719) 457-2620, passcode 8806446. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://edge.media-server.com/m/p/otq2n4qy/lan/en, or http://www.thoratec.com.

A replay of the conference call will be available through Tuesday, May 8, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode 8806446.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Comments on February 23rd Voluntary Medical Device Correction Notification
2. Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast
3. Thoratec Schedules Fourth Quarter Conference Call, Webcast
4. Thoratec Announces Appointment of William A. Hawkins to Board of Directors
5. Thoratec Presentation at Oppenheimer Conference to Be Webcast
6. Thoratec Corporation Authorizes Additional $50 Million Share Repurchase Program
7. Thoratec Reports Third Quarter Fiscal 2011 Results
8. Thoratec Schedules Third Quarter Conference Call, Webcast
9. Thoratec Presentation at Lazard Capital Markets Circulatory Assist Device Day to be Webcast
10. Thoratec Announces Presentations at Upcoming Investor Conferences
11. Thoratec Reports Second Quarter Revenue Increase of 17 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Inc. today announced the appointment of Martyn Coombs as ... of ImaginAb, said "At ImaginAb we have exciting science and technology. ... our business, particularly in commercializing and making step changes in the ... realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear medicine and ...
(Date:3/22/2017)... N.J. , March 22, 2017  CANTEL MEDICAL CORP. ... B. Hansen , President and CEO, will be presenting at ... at the Westin Grand Central Hotel in New ... April 5, 2017 at 3:00 p.m. ET. In addition, management ... A live audio webcast will be available ...
(Date:3/22/2017)... 22, 2017 Research and Markets has ... Inhibitors Market & Clinical Pipeline Insight 2022" drug pipelines ... ... Clinical Pipeline Insight 2022 report gives comprehensive insight on clinical ... immune check point inhibitors as main streamline drugs in the ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Sam & Associates Insurance Agency, ... and related services to residents of the region, is embarking on a charity ... and wild lands. , Endangered Species International is committed to ending the anthropogenic ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society for ... (PA) form for prescribers to improve patients’ access to the revolutionary therapy for ... as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues and ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition ... print media enterprise focused on cancer patients, cancer centers and advocacy groups, and ... 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal ...
(Date:3/22/2017)... ... March 22, 2017 , ... Influence Health, ... marketing solutions have enabled Children’s Hospital of The King’s Daughters (CHKD) to achieve ... the value of a digital marketing approach, the 206-bed pediatric teaching hospital in ...
Breaking Medicine News(10 mins):